3052.0 Drug Policy & Pharmacy Services

Monday, November 8, 2010: 8:30 AM - 10:00 AM
This session will address safety and access issues to pharmaceuticals, both domestic and international, including how consumers may respond to new social media attempts by the pharmaceutical industry. Access and cost issues under Medicare Part D will be examined along with how emerging economies with domestic pharmaceutical capacity are dealing with multinationals to promote drug access for persons with HIV/AIDS. Analysis of FDA approvals of antibiotics concludes the session.
Session Objectives: 1. Discuss both domestic and international current issues in health policy related to the use of pharmaceuticals. 2. Explain how the pharmaceutical industry interacts with consumers. 3. Discuss how the pharmaceutical industry is developing worldwide with implications to drug access.

Safety of the U.S. prescription drug supply
Gabrielle Cosel, MSc Human Rights and Allan Coukell, BSc Pharm
Do the internet and popular culture provide international direct-to-consumer drug advertising? A social-media based pilot survey
Ano L. Lobb, MPH, Oren Mechanic, MPH, Amanda Graver, MPH, Claire Manneh, MPH, Michael Rezaee, MPH and Desiree Fehmie, MPH
Promoting access and reducing out-of-pocket prescription drug costs for vulnerable Medicare patients
Amanda R. Smith, MPH, Timothy W. Cutler, PharmD, Marilyn R. Stebbins, PharmD and Helene Levens Lipton, PhD
Analysis of Systemic Antibiotics Approved in the U.S. between 1980 and 2009
Kevin Outterson, JD, LLM, Rosa Rodriguez-Monguio, PhD, Enrique Seoane-Vazquez, PhD and John Powers, MD

See individual abstracts for presenting author's disclosure statement and author's information.

Organized by: Medical Care
Endorsed by: Social Work, Trade and Health Forum

CE Credits: Medical (CME), Health Education (CHES), Nursing (CNE), Public Health (CPH)

See more of: Medical Care